739 results on '"Brewer, George J."'
Search Results
2. Contributors
3. Copper
4. Background on Copper, Including Why Copper-2 Is So Specifically Neurotoxic
5. Prevention Measures Action Items
6. The Copper Hypothesis Fits Nicely With Known Risk Factors and Theories of Alzheimer’s Disease Causation
7. Failures
8. Introduction
9. Candidate Environmental Factors for the Alzheimer’s Epidemic Part 2
10. Interesting and Important Historical and Demographic Facts About the Epidemic of Alzheimer’s Disease in Developed Countries Pointing to Environmental Intoxicants Causing the Epidemic
11. A Little Background on Dementia and Alzheimer’s Disease
12. Summary and Conclusions
13. Candidate Environmental Factors for the Alzheimer’s Epidemic Part 1
14. Identification of Copper-2 and Copper in General, as Major Environmental Intoxicants in the Alzheimer’s Disease Epidemic
15. Inorganic Copper, or Copper-2, Ingestion as a Major Causal Factor for the Alzheimer’s Disease Epidemic—The Web of Evidence
16. Treatment of Alzheimer’s Disease
17. Increased Copper Absorption Resulting From Dietary Changes in Developed Countries as Another Causal Factor in the Alzheimer’s Disease Epidemic
18. Wilson’s Disease
19. History, Important Milestones, and the Future
20. Description of the Anticopper Drugs Which are Used in Wilson’s Disease Therapy
21. Therapy of the Presymptomatic, the Pediatric, and the Pregnant Patient
22. Maintenance Therapy
23. Initial Treatment of Patients Who Present with Neurologic and/or Psychiatric Disease
24. Simple Approaches to Screening and Definitive Diagnosis
25. Initial Treatment of Patients Who Present with Liver Disease
26. Overview of Management for the Clinician: What’s Important and What’s Not
27. The Clinician’s Challenge: Recognizing Wilson’s Disease
28. Overview of the Disease for the Clinician
29. Disease Pathology
30. Disease Pathogenesis and Genetics
31. Risk Factors during Maintenance Therapy and Prognosis
32. The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease
33. Copper in Wilson’s and Alzheimer’s Diseases, Copper-Lowering Therapy in Cancer and Other Diseases, and Copper Deficiency
34. List of Contributors
35. Wilson’s Disease
36. Control of Copper in Wilson’s Disease and Diseases of Neovascularization, such as Cancer
37. Metals in the causation and treatment of Wilson’s disease and Alzheimer’s disease, and copper lowering therapy in medicine
38. The Treatment of Wilson&’s Disease
39. Copper toxicity in Alzheimer's disease: Cognitive loss from ingestion of inorganic copper
40. Prognostic significance of neurologic examination findings in Wilson disease
41. Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial
42. Human and Canine Inherited Copper Toxicosis: Copper Balance Regulation and Molecular Genetics of Its Impairment
43. Drug development for orphan diseases in the context of personalized medicine
44. Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine
45. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc
46. The 4.1-Like Proteins of the Bovine Lens: Spectrin-Binding Proteins Closely Related in Structure to Red Blood Cell Protein 4.1
47. Erthrocyte Metabolism: Interaction with Oxygen Transport
48. Studies of Isozyme Patterns in Nullisomic-Tetrasomic Combinations of Hexaploid Wheat
49. The Relationship between Red Cell 2,3-diphosphoglycerate and Levels of Hemoglobin in the Human
50. A Study of the Relationship between the Content of Adenosine Triphosphate in Human Red Cells and the Course of Falciparum Malaria: A New System that may Confer Protection against Malaria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.